Cargando…

In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection

INTRODUCTION: Human immunodeﬁciency virus (HIV) remains a persistent global challenge, impacting 38 million people worldwide. Antiretrovirals (ARVs) including tenofovir (TFV), raltegravir (RAL), and dapivirine (DAP) have been developed to prevent and treat HIV-1 via different mechanisms of action. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minooei, Farnaz, Fried, Joel R, Fuqua, Joshua L, Palmer, Kenneth E, Steinbach-Rankins, Jill M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894819/ https://www.ncbi.nlm.nih.gov/pubmed/33623382 http://dx.doi.org/10.2147/IJN.S287310

Ejemplares similares

Improving the large scale purification of the HIV microbicide, griffithsin
por: Fuqua, Joshua L, et al.
Publicado: (2015)

Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms
por: Desai, Hetal, et al.
Publicado: (2020)

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin
por: Nabeta, Henry W., et al.
Publicado: (2021)

Bulk production of the antiviral lectin griffithsin
por: Fuqua, Joshua L., et al.
Publicado: (2015)

Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis
por: Nabeta, Henry W., et al.
Publicado: (2022)

Synergistic anti-HIV-1 activity of griffithsin with tenofovir, maraviroc and enfuvirtide
por: Férir, Geoffrey, et al.
Publicado: (2011)

Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention
por: Kramzer, Lindsay F., et al.
Publicado: (2021)

Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing
por: Alam, Aatif, et al.
Publicado: (2018)

Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
por: Tyo, Kevin M., et al.
Publicado: (2019)

In Preparation for Outdoor Pharming: Griffithsin Can Be Expressed in Nicotiana excelsiana and Retains Activity After Storage as Silage
por: Eapen, Paul, et al.
Publicado: (2020)

Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis
por: Yang, Haitao, et al.
Publicado: (2019)

BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis–Streptococcus gordonii biofilms
por: Mahmoud, Mohamed Y., et al.
Publicado: (2018)

Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)
por: Cash, Elizabeth, et al.
Publicado: (2023)

Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin
por: Millet, Jean K., et al.
Publicado: (2016)

Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosa
por: Günaydın, Gökçe, et al.
Publicado: (2019)

Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture
por: Shrivastava-Ranjan, Punya, et al.
Publicado: (2020)

Pharmacokinetics of the Antiviral Lectin Griffithsin Administered by Different Routes Indicates Multiple Potential Uses
por: Barton, Christopher, et al.
Publicado: (2016)

Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge
por: Lo, Michael K, et al.
Publicado: (2020)

Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primates
por: Girard, Lauren, et al.
Publicado: (2018)

Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential
por: Lusvarghi, Sabrina, et al.
Publicado: (2016)

Studies in a Murine Model Confirm the Safety of Griffithsin and Advocate Its Further Development as a Microbicide Targeting HIV-1 and Other Enveloped Viruses
por: Kouokam, Joseph Calvin, et al.
Publicado: (2016)

Domain-Swapped Structure of the Potent Antiviral Protein Griffithsin and Its Mode of Carbohydrate Binding
por: Ziółkowska, Natasza E., et al.
Publicado: (2006)

Rice endosperm is cost‐effective for the production of recombinant griffithsin with potent activity against HIV
por: Vamvaka, Evangelia, et al.
Publicado: (2016)

Porcine deltacoronavirus infection is inhibited by Griffithsin in cell culture
por: Tang, Rongfeng, et al.
Publicado: (2022)

Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virus
por: Moulaei, Tinoush, et al.
Publicado: (2015)

A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4(+) cell distribution in the human rectal mucosa
por: Franzén Boger, Mathias, et al.
Publicado: (2023)

Characterization of the hypersensitive response‐like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathway
por: Kim, Bo Min, et al.
Publicado: (2018)

Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo
por: Ishag, Hassan Z. A., et al.
Publicado: (2012)

Grifonin-1: A Small HIV-1 Entry Inhibitor Derived from the Algal Lectin, Griffithsin
por: Micewicz, Ewa D., et al.
Publicado: (2010)

Role of the Carbohydrate-Binding Sites of Griffithsin in the Prevention of DC-SIGN-Mediated Capture and Transmission of HIV-1
por: Hoorelbeke, Bart, et al.
Publicado: (2013)

Gene-silencing suppressors for high-level production of the HIV-1 entry inhibitor griffithsin in Nicotiana benthamiana
por: Habibi, Peyman, et al.
Publicado: (2018)

Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate
por: Kouokam, Joseph Calvin, et al.
Publicado: (2011)

Crystallographic studies of the complexes of antiviral protein griffithsin with glucose and N-acetylglucosamine
por: Ziółkowska, Natasza E., et al.
Publicado: (2007)

Low-Cost, Large-Scale Production of the Anti-viral Lectin Griffithsin
por: Decker, John S., et al.
Publicado: (2020)

In vitro antiviral activity of Griffithsin against porcine epidemic diarrhea virus
por: Li, Lan, et al.
Publicado: (2019)

Griffithsin inhibits porcine reproductive and respiratory syndrome virus infection in vitro
por: Li, Lan, et al.
Publicado: (2018)

An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo
por: Zhao, Yajing, et al.
Publicado: (2022)

Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity
por: Moulaei, Tinoush, et al.
Publicado: (2010)

Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus
por: Levendosky, Keith, et al.
Publicado: (2015)

Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling
por: Sims, Lee B, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3d2b5nbd39ebr82q9a02jmj4kl